Sec. 4. (a) As used in this chapter, "biomarker testing" means the analysis of a patient's tissue, blood, or other biospecimen for the presence of a biomarker. (b) The term includes: (1) single-analyte tests; (2) multiplex panel tests; (3) protein expression; and (4) whole exome, whole genome, and whole transcriptome sequencing. As added by P.L.37-2024, SEC.2.
"Biomarker testing"
Ind. Code § 27-8-14.3-4, under Coverage for Biomarker Testing.
Ind. Code § 27-8-14.3-4